125 related articles for article (PubMed ID: 26993034)
1. Panimmunoglobulin and IgE-selective extracorporeal immunoadsorption in patients with severe atopic dermatitis.
Reich K; Deinzer J; Fiege AK; von Gruben V; Sack AL; Thraen A; Weisenseel P; Breuer K; Jäckle S; Meier M
J Allergy Clin Immunol; 2016 Jun; 137(6):1882-1884.e6. PubMed ID: 26993034
[No Abstract] [Full Text] [Related]
2. Targeting IgE in Severe Atopic Dermatitis with a Combination of Immunoadsorption and Omalizumab.
Zink A; Gensbaur A; Zirbs M; Seifert F; Suarez IL; Mourantchanian V; Weidinger S; Mempel M; Ring J; Ollert M
Acta Derm Venereol; 2016 Jan; 96(1):72-6. PubMed ID: 26059424
[TBL] [Abstract][Full Text] [Related]
3. IgE-specific immunoadsorption: New treatment option for severe refractory atopic dermatitis.
Wegner J; Saloga J; Grabbe S; Wilden S; Vewinger N; Lutz J; Weinmann-Menke J; von Stebut E
Allergy; 2019 Jun; 74(6):1190-1193. PubMed ID: 30636038
[No Abstract] [Full Text] [Related]
4. Improvement of treatment-refractory atopic dermatitis by immunoadsorption: a pilot study.
Kasperkiewicz M; Schmidt E; Frambach Y; Rose C; Meier M; Nitschke M; Falk TM; Reich K; Ludwig RJ; Zillikens D
J Allergy Clin Immunol; 2011 Jan; 127(1):267-70, 270.e1-6. PubMed ID: 20970174
[No Abstract] [Full Text] [Related]
5. Repetitive immunoadsorption cycles for treatment of severe atopic dermatitis.
Daeschlein G; Scholz S; Lutze S; Eming R; Arnold A; Haase H; Hertl M; Jünger M
Ther Apher Dial; 2015 Jun; 19(3):279-87. PubMed ID: 25511754
[TBL] [Abstract][Full Text] [Related]
6. IgE-specific immunoadsorption for treatment of recalcitrant atopic dermatitis.
Kasperkiewicz M; Süfke S; Schmidt E; Zillikens D
JAMA Dermatol; 2014 Dec; 150(12):1350-1. PubMed ID: 25271706
[No Abstract] [Full Text] [Related]
7. Immunoadsorption for treatment of severe atopic dermatitis.
Wegner J; Weinmann-Menke J; von Stebut E
Atheroscler Suppl; 2017 Nov; 30():264-270. PubMed ID: 29096848
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin E-Selective Immunoadsorption Reduces Peripheral and Skin-Bound Immunoglobulin E and Modulates Cutaneous IL-13 Expression in Severe Atopic Dermatitis.
Reich K; Hartjen A; Reich J; Schröder J; Steingrube N; Bresch M; Ertas B; Falk TM; Blödorn-Schlicht N; Jäckle S; Meier M
J Invest Dermatol; 2019 Mar; 139(3):720-723. PubMed ID: 30365931
[No Abstract] [Full Text] [Related]
9. Effects of Intramuscular Injection of Autologous Immunoglobulin on Clinical Severity and Serum IgE Concentration in Patients with Atopic Dermatitis.
Nahm DH; Kim ME; Cho SM
Dermatology; 2015; 231(2):145-51. PubMed ID: 26112673
[TBL] [Abstract][Full Text] [Related]
10. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
Bussmann C; Maintz L; Hart J; Allam JP; Vrtala S; Chen KW; Bieber T; Thomas WR; Valenta R; Zuberbier T; Sager A; Novak N
Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407
[TBL] [Abstract][Full Text] [Related]
11. Malassezia spp.-specific immunoglobulin E level is a marker for severity of atopic dermatitis in adults.
Glatz M; Buchner M; von Bartenwerffer W; Schmid-Grendelmeier P; Worm M; Hedderich J; Fölster-Holst R
Acta Derm Venereol; 2015 Feb; 95(2):191-6. PubMed ID: 24696225
[TBL] [Abstract][Full Text] [Related]
12. Frequency of raised serum IgE level in childhood atopic dermatitis.
Ahmed I; Nasreen S
J Pak Med Assoc; 2007 Sep; 57(9):431-4. PubMed ID: 18072635
[TBL] [Abstract][Full Text] [Related]
13. Interferon-alpha treatment decreases the number of blood eosinophils in patients with severe atopic dermatitis.
Paukkonen K; Fräki J; Horsmanheimo M
Acta Derm Venereol; 1993 Apr; 73(2):141-2. PubMed ID: 8103263
[TBL] [Abstract][Full Text] [Related]
14. Relationship between serum levels of interleukin-18, IgE and disease severity in patients with atopic dermatitis.
Trzeciak M; Gleń J; Bandurski T; Sokołowska-Wojdyło M; Wilkowska A; Roszkiewicz J
Clin Exp Dermatol; 2011 Oct; 36(7):728-32. PubMed ID: 21689145
[TBL] [Abstract][Full Text] [Related]
15. Decrease in circulating Th17 cells correlates with increased levels of CCL17, IgE and eosinophils in atopic dermatitis.
Hayashida S; Uchi H; Moroi Y; Furue M
J Dermatol Sci; 2011 Mar; 61(3):180-6. PubMed ID: 21255981
[TBL] [Abstract][Full Text] [Related]
16. High serum total IgE predicts poor long-term outcome in atopic dermatitis.
Kiiski V; Karlsson O; Remitz A; Reitamo S
Acta Derm Venereol; 2015 Nov; 95(8):943-7. PubMed ID: 25916555
[TBL] [Abstract][Full Text] [Related]
17. Are age-specific high serum IgE levels associated with worse symptomatology in children with atopic dermatitis?
Hon KL; Lam MC; Leung TF; Wong KY; Chow CM; Fok TF; Ng PC
Int J Dermatol; 2007 Dec; 46(12):1258-62. PubMed ID: 18173519
[TBL] [Abstract][Full Text] [Related]
18. THE LEVEL OF GENERAL IMMUNOGLOBULIN E (IGE) IN RATS OF DIFFERENT AGE WITH ATOPIC DERMATITIS.
Bereznyakova AI; Jemela OD; Cheremisina VF
Fiziol Zh (1994); 2016; 62(1):92-4. PubMed ID: 29537206
[TBL] [Abstract][Full Text] [Related]
19. An open study to assess the efficacy clinically and immunologically of M. vaccae vaccine in patients with atopic dermatitis.
Davies MG; Symons C; Shaw S; Kaminski ER
J Dermatolog Treat; 2006; 17(2):74-7. PubMed ID: 16766329
[TBL] [Abstract][Full Text] [Related]
20. Topical clofibrate improves symptoms in patients with atopic dermatitis and reduces serum TARC levels: a randomized, double-blind, placebo-controlled pilot study.
Fukaya M; Kimata H
J Drugs Dermatol; 2014 Mar; 13(3):259-63. PubMed ID: 24595568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
